Corteva, Inc. (NYSE:CTVA) Receives $90.19 Average Target Price from Analysts

Corteva, Inc. (NYSE:CTVA) has earned a consensus recommendation of “Moderate Buy” from the twenty-three analysts that are presently covering the firm, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $91.3810.

A number of equities analysts recently weighed in on the stock. Royal Bank Of Canada lifted their target price on shares of Corteva from $97.00 to $103.00 and gave the stock an “outperform” rating in a research note on Tuesday, July 21st. Bank of America increased their price target on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a report on Monday, July 20th. Mizuho lifted their price objective on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a research note on Tuesday, July 14th. The Goldman Sachs Group increased their target price on shares of Corteva from $88.00 to $96.00 and gave the stock a “buy” rating in a research note on Tuesday, April 14th. Finally, Zacks Research upgraded shares of Corteva from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th.

Corteva Price Performance

Shares of CTVA opened at $78.18 on Friday. The business has a 50-day simple moving average of $82.05 and a two-hundred day simple moving average of $79.73. Corteva has a 12-month low of $60.53 and a 12-month high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock has a market cap of $52.16 billion, a PE ratio of 51.77, a PEG ratio of 2.31 and a beta of 0.57.

Corteva (NYSE:CTVA) last announced its earnings results on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a return on equity of 10.18% and a net margin of 5.66%.The firm had revenue of $6.38 billion for the quarter, compared to the consensus estimate of $6.60 billion. During the same period in the previous year, the business earned $2.20 EPS. The business’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts anticipate that Corteva will post 3.74 earnings per share for the current fiscal year.

Corteva Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be issued a $0.18 dividend. The ex-dividend date is Tuesday, September 1st. This represents a $0.72 annualized dividend and a yield of 0.9%. Corteva’s dividend payout ratio is presently 47.68%.

Hedge Funds Weigh In On Corteva

Institutional investors have recently modified their holdings of the company. Brighton Jones LLC increased its position in shares of Corteva by 307.2% during the fourth quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after acquiring an additional 11,760 shares in the last quarter. Woodline Partners LP raised its position in Corteva by 40.3% in the 1st quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after buying an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC lifted its stake in Corteva by 62.1% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after acquiring an additional 980 shares in the last quarter. Cresset Asset Management LLC boosted its holdings in Corteva by 2.6% during the 2nd quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after acquiring an additional 181 shares during the last quarter. Finally, Jump Financial LLC purchased a new position in Corteva during the 2nd quarter worth $1,464,000. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.